Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.jdiacomp.2016.07.018

http://scihub22266oqcxt.onion/10.1016/j.jdiacomp.2016.07.018
suck pdf from google scholar
C5435122!5435122!27522272
unlimited free pdf from europmc27522272    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid27522272      J+Diabetes+Complications 2016 ; 30 (8): 1467-72
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease #MMPMID27522272
  • Dieter BP; McPherson SM; Afkarian M; de Boer IH; Mehrotra R; Short R; Barbosa-Leiker C; Alicic RZ; Meek RL; Tuttle KR
  • J Diabetes Complications 2016[Nov]; 30 (8): 1467-72 PMID27522272show ga
  • Aims: To determine if serum levels of serum amyloid A (SAA) predict death and end-stage renal disease in a cohort of people with diabetic kidney disease. Methods: In a longitudinal cohort study of 135 participants with type 2 diabetes and diabetic kidney disease, serum samples were assayed for SAA. Censored time-to-event analyses in Cox-proportional hazard models were utilized to assess SAA as a predictor of the primary outcome of death and end-stage renal disease. Results: Participants were 73% Mexican-American (99/135) and 55% men (75/135), with a mean ± SD age of 57 ± 7.5 years. At baseline, participants had hemoglobin A1c of 8.6 ± 2.3%, systolic blood pressure of 153 ± 27 mm Hg, body mass index of 31 ± 9 kg/m2, median urine-albumin-to-creatinine ratio of 1861 mg/g (interquartile range 720?3912 mg/g), and estimated glomerular filtration rate of 55.7 ± 22.3 ml/min/1.73 m2. Over a median duration of follow-up of 3.5 years, 44% (60/135)of participants experienced a primary outcome event. The hazards ratio for the primary outcome was 3.03 (95% CI 1.43?6.40, p = 0.003) in the highest (>1.0 ?g/ml) compared to the lowest (<0.55 ?g/ml) SAA tertile in a model adjusted for urine-albumin-to-creatinine ratio, estimated glomerular filtration rate, age, sex, and race/ethnicity. Addition of SAA as a covariate improved the model C-statistic (? c = 0.017). Conclusions: In a longitudinal cohort study of participants with type 2 diabetes and DKD, higher levels of serum SAA predicted higher risk of death and ESRD. SAA is a promising targetable biomarker for DKD.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box